Skip to content
Share
Explore
Sales
Add & Qualify Companies
Add & Qualify Companies
Review your AI Qualified Leads ✨
Clear Sample Rows
Add row
Companies
AI Priority ✨
Logo
Company
Review Lead
AI Analysis ✨
HQ Location
Description
Domain
Tier 1
2
Qualified: The company meets all criteria for target industry and funding stage, but the funding amount is unknown.
Tel Aviv-yafo, Tel Aviv, Israel
Healthy.io converts smartphone cameras into a clinical grade medical device.
Tier 2
2
Zip
Review
Qualified: The company Zip meets all the criteria for qualification. The target industry includes finance and information technology, the company has 50-500 employees, and the funding stage is Series C. Although the funding amount is not specified, the company's description suggests that it has significant financing.
San Francisco, California, USA
Zip is an Intake-to-Pay platform for any employee to initiate a purchase or vendor request.
Allica Bank
Review
Qualified: The company meets the target industry criteria of Finance and the target funding criteria of Series C financing or higher. However, there is no information provided for funding amount. Manual Review is needed to confirm if the funding amount is at least ~$100,000,000.
London, England, UK
Allica Bank is a fintech company that delivers digital banking services for small and medium-sized businesses.
Tier 3
2
Cleo
Review
Manual Review: The company meets the target industries criteria, but there is no information on the funding amount. Additionally, the description mentions finance and financial services, but it is unclear if the company specifically targets the finance industry. Further investigation is needed to determine if the company qualifies.
London, England, UK
Cleo turns your complicated financial life into a conversation – the same kind you’d have with a friend.
Disqualified
41
Amino
Review
Disqualified: No funding amount provided.
San Francisco, California, USA
Amino is a data-driven healthcare guidance platform that helps companies and their employees navigate the complex US healthcare system.
BenchSci
Review
Disqualified: Funding amount is less than $100,000,000 and is not Series C financing or higher.
Toronto, Ontario, Canada
BenchSci uses machine learning and artificial intelligence to accelerate biomedical discoveries.
Boundless Bio
Review
Disqualified: Funding amount is below the required threshold of $100,000,000 for financing.
La Jolla, California, USA
Boundless Bio is a precision oncology company developing therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers.
OpenFin
Review
Disqualified: Funding amount is lower than the required $100,000,000 or Series C financing or higher.
New York, New York, USA
OpenFin provides financial institutions with a unified workspace and developer platform built for productivity.
The EVERY Company
Review
Disqualified: Target industry does not match any of the criteria. Manual review may be necessary as the company has potential in the technology industry but also operates in other industries. Funding information is not provided.
South San Francisco, California, USA
The EVERY Company makes real animal protein without the use of a single animal, starting with chicken-less egg proteins.
Wellthy
Review
Disqualified: Funding amount is less than $100,000,000 and Funding Stage is not Series C or higher.
New York, New York, USA
Wellthy is a family care concierge service that brings relief to families managing complex or ongoing care situations.
Fabrick
Review
Disqualified: No funding amount provided
Milan, Lombardia, Italy
Fabrick is a financial services company that offers solutions to provide their customers with a wide range of digital payments.
Clue
Review
Disqualified: Funding amount is not provided and the funding stage is Equity Crowdfunding, which does not meet the requirement of at least ~$100,000,000 or Series C financing or higher. Although the company is in the healthcare industry, it does not meet the target number of employees criteria of 50-500 employees.
Berlin, Berlin, Germany
Clue is a female health application for period and fertility tracking.
Recursion Pharmaceuticals
Review
Disqualified: Funding amount is less than $100,000,000 and not at Series C financing or higher.
Salt Lake City, Utah, USA
Recursion Pharmaceuticals is a digital biology company, developing a drug discovery platform and pipeline with machine learning.
VectivBio
Review
Disqualified: Funding Amount is missing.
Basel, Switzerland
VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.
MPOWER Financing
Review
Disqualified: Funding amount is less than $100,000,000 and funding stage is not Series C or higher.
Washington, D.C., USA
MPOWER Financing is a fintech company that provides educational loans to domestic and international students.
Marshmallow
Review
Disqualified: The funding amount falls below the required minimum of $100,000,000 for financing, and the funding stage is Series B, which is lower than the required Series C financing or higher.
London, England, UK
Marshmallow is a full-stack insurance carrier driven by technology.
Enveda Biosciences
Review
Disqualified: The company does not meet the funding requirement of at least $100,000,000 or Series C financing or higher.
Boulder, Colorado, USA
Enveda Biosciences is a biotechnology company engineering new drugs from plants.
Hallow
Review
Disqualified: Funding amount does not meet the minimum requirement of ~$100,000,000 or Series C financing or higher.
Chicago, Illinois, USA
Hallow is a Catholic prayer and meditation app that hopes to help people grow closer to God.
Wefunder
Review
Disqualified: Funding amount is less than $100,000,000 and funding stage is only at the Seed level.
San Francisco, California, USA
Wefunder is a crowd investing platform that offers capital raising services.
YgEia3
Review
Disqualified: Funding amount is less than $100,000,000 and funding stage is not Series C or higher.
London, England, UK
YgEia3 works with corporations developing comprehensive wellness testing for each company.
GetVantage
Review
Disqualified: Funding amount is below the required threshold of at least $100,000,000 or Series C financing or higher.
Mumbai, Maharashtra, India
GetVantage is a fintech platform providing access to equity-free working capital, business optimisation tools, and a founder's community.
Voyager
Review
Disqualified: The funding amount is less than $100,000,000 and the funding stage is Post-IPO Equity, which does not meet the criteria of at least Series C financing or higher.
Wilmington, Delaware, USA
Voyager offers a secure way to invest in cryptocurrencies and altcoins using its mobile application.
Cyclica
Review
Disqualified: Funding amount is below the minimum requirement of ~$100,000,000 or Series C financing or higher.
Toronto, Ontario, Canada
Cyclica is a company that creates patented cloud-based predictive analytics software to find safer and more effective medicines.
Ocugen
Review
Disqualified: Funding amount is less than $100,000,000 and not Series C financing or higher.
Malvern, Pennsylvania, USA
Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.
Liquid Death
Review
Disqualified: Funding amount is less than $100,000,000 and funding stage is Series D, which does not meet the funding criteria.
Santa Monica, California, USA
Liquid Death is a non-alcoholic beverage brand that is focused on health and sustainability.
Memora Health
Review
Disqualified: The company does not meet the funding criteria. Their funding amount is below the required ~$100,000,000 and they have not reached Series C financing or higher.
San Francisco, California, USA
The leading intelligent care enablement platform to simplify how patients and clinicians navigate complex care delivery.
CareAcademy
Review
Disqualified: Funding amount is below the minimum requirement of $100,000,000 or Series C financing or higher.
Cambridge, Massachusetts, USA
CareAcademy offers an online training empowering senior care professionals to deliver the highest caliber of services.
Augmedix
Review
Disqualified: Funding amount is less than $100,000,000 and funding stage is Post-IPO Equity, which is lower than Series C financing.
San Francisco, California, USA
Augmedix is an automated medical documentation and data services for healthcare systems, hospitals, practices, and more.
Axuall
Review
Disqualified: The company does not meet the funding criteria. Its funding stage is Series B and funding amount is less than $100,000,000.
Cleveland, Ohio, USA
Axuall is a workforce intelligence company providing data and insights for network planning, analytics, and credentialing for healthcare.
Reveleer
Review
Disqualified: Funding amount is below the required threshold of $100,000,000 or Series C financing or higher.
Glendale, California, USA
Reveleer is a healthcare SaaS platform that uses ML and AI to empower health plans with control over their quality and risk programs.
Ensoma
Review
Disqualified: The company does not meet the funding criteria. Their funding stage is Series B and their funding amount is $1M to $10M, which is below the required financing of at least ~$100,000,000 or Series C financing or higher.
Boston, Massachusetts, USA
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Krystal Biotech
Review
Disqualified: Funding amount is below the required threshold of $100,000,000.
Pittsburgh, Pennsylvania, USA
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
Vedanta Biosciences
Review
Disqualified: The funding amount is less than the required amount.
Cambridge, Massachusetts, USA
Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
54gene
Review
Disqualified: Funding amount is not provided, and the funding stage is Series B which is lower than the required Series C or higher.
Washington, D.C., USA
54gene is a healthcare startup that offers a genetics testing platform.
Wysa
Review
Disqualified: Funding amount is not provided.
Bangalore, Karnataka, India
Wysa is a mental health wellness platform that helps individuals in managing their mental and emotional stress.
Northern Arc
Review
Disqualified: Funding amount is less than $100,000,000 and funding stage is not Series C or higher.
Chennai, Tamil Nadu, India
Northern Arc Capital is a non-banking finance company that provides access to debt for under-served investors and businesses.
Inbox Health
Review
Disqualified: Funding amount is below the required $100,000,000 or Series C financing or higher.
New Haven, Connecticut, USA
Inbox Health is a digital healthcare company that designs a tool to automate bills and give patients additional insights into their charges.
Oshi Health
Review
Disqualified: Funding amount is below the minimum threshold of $100,000,000 for financing.
New York, New York, USA
Oshi Health is a digital health platform that provides personalized support and resources for people with digestive health conditions.
Colossal Biosciences
Review
Disqualified: Funding amount is not provided.
Dallas, Texas, USA
Colossal is a bioscience and genetic engineering company focused on de-extinction of past species.
HeartFlow
Review
Disqualified: Funding amount does not meet the minimum requirement of $100,000,000 for financing or Series C financing or higher.
Redwood City, California, USA
HeartFlow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.
Uwill
Review
Disqualified: No funding amount provided.
Natick, Massachusetts, USA
Uwill is an online therapy platform that connects college students to mental health professionals.
LIQUiDITY Group
Review
Disqualified: No funding amount provided.
New York, New York, USA
Liquidity Group is a fintech firm that specializes in providing non-dilutive, and unsecured capital to SaaS-based companies.
Cedar
Review
Disqualified: The funding amount is below the required amount of $100,000,000 and the funding stage is not Series C or higher.
New York, New York, USA
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevates the patient experience.
Monese
Review
Disqualified: Funding amount is below the required threshold of $100,000,000 or Series C financing or higher.
London, England, UK
Monese is a digital banking option that provides mobile-only, multi-currency accounts in countries across the European Economic Area.
Want to print your doc?
This is not the way.
This is not the way.
Try clicking the ⋯ next to your doc name or using a keyboard shortcut (
CtrlP
) instead.